None listed
Conditions
Interventions
Procedure/Surgery : Among the patients evaluated with a GDS score of 3-5 for neurological treatment at Asan Medical Center in Seoul between December 31, 2025, the study was conducted on 114 patients (
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Between December 31, 2025, from the IRB approval date to December 31, 2025, among patients with intracranial lymphoma circulation disorders evaluated with a GDS score of 3-5, we plan to take amyloid PET CT and conduct a study on Alzheimer's disease patients whose accumulation of amyloid due to lymphoid circulation disorders was objectively confirmed.
Exclusion criteria
Exclusion criteria: - Patients under 45 years of age and over 80 years of age are excluded. -Except when follow-up observation is not possible for more than 12 months. -Patients with vascular dementia are excluded. -Patients with organic brain disease are excluded. -Patients with indocyanine green (ICG) hypersensitivity are excluded. -Except for cases where general health is not controlled due to a serious medical condition. -Patients with a history of past surgery in the neck are excluded. -Except if you do not want to or have not filled out the consent form. -Other than the above matters, cases where it is deemed difficult to conduct clinical trials at the judgment of the clinical trial director shall be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive function evaluation | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative side effects | — |
Countries
Korea, Republic of
Contacts
Public Contactjuhee hwang
Asan Medical Center
Outcome results
None listed